FIELD: medicine. SUBSTANCE: method involves examining peripheral blood samples taken from leprosy patients for determining endogenous aldosterone level and intensity of lymphocyte blast transformation response to phytohemagglutinin. Leprous nodular erythema development risk index being found equal to or greater than 24.1, leprous nodular erythema development is predicted. EFFECT: enhanced accuracy of prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
| METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
| METHOD OF IDENTIFICATION OF MYCOBACTERIUM LEPRAE IN PATIENTS WITH DISEASE REGRESSION | 1997 |
|
RU2137137C1 |
| METHOD OF TREATMENT OF CHRONIC NEURITIDES IN PATIENTS ILL WITH LEPRA | 1996 |
|
RU2135152C1 |
| METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
| METHOD FOR PREDICTING EXACERBATION OF LEPROUS NEUROPATHIES IN PATIENTS AT LEPROSY | 2006 |
|
RU2310393C1 |
| METHOD FOR PREDICTING LEPROSY PATIENT TREATMENT EFFECTIVENESS | 2003 |
|
RU2247374C1 |
| METHOD FOR DETECTING ACTIVITY OF LEPROUS PROCESS | 2002 |
|
RU2231065C2 |
| METHOD OF PREDICTING SERIOUS COURSES OF LEPROTIC POLYNEURITES | 2007 |
|
RU2350955C1 |
| METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
